» Authors » Amalia Gomez-Bernal

Amalia Gomez-Bernal

Explore the profile of Amalia Gomez-Bernal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 27
Followers 0
Related Specialty
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Martinez-Janez N, Chacon I, de Juan A, Cruz-Merino L, Del Barco S, Fernandez I, et al.
Breast Care (Basel) . 2016 May; 11(2):133-8. PMID: 27239176
Background: The aim of this project was to provide an expert opinion regarding anti-human epidermal growth factor receptor 2 (HER2) therapy beyond second-line treatment of metastatic breast cancer (mBC). Methods:...
2.
Bayo-Calero J, Mayordomo J, Sanchez-Rovira P, Perez-Carrion R, Illaramendi J, Garcia-Bueno J, et al.
Clin Breast Cancer . 2008 Jul; 8(3):264-8. PMID: 18650157
Background: Trastuzumab combined with cytotoxic agents presents encouraging results in metastatic breast cancer (MBC), but cardiac toxicity limits some combinations. The synergism shown with trastuzumab and the favorable tolerability profile...
3.
Salazar R, Cruz-Hernandez J, Sanchez-Valdivieso E, Rodriguez C, Gomez-Bernal A, Barco E, et al.
Cancer Lett . 2005 May; 233(1):172-7. PMID: 15876480
We carried out a mutational analysis of BRCA1 and BRCA2 genes in 103 individuals from a population in Western Central Spain and we identified nine new variants: two truncating mutations...
4.
Gomez-Bernal A, Cruz J, Olaverri A, Arizcun A, Martin T, Rodriguez C, et al.
Anticancer Drugs . 2004 Dec; 16(1):77-82. PMID: 15613908
This phase II trial evaluated the efficacy and toxicity of vinorelbine 25 mg/m2 plus docetaxel 60 mg2/m administered on day 1, every 2 weeks with granulocyte colony-stimulating factor support (G-CSF,...
5.
Gomez-Bernal A, Cruz J, Garcia-Palomo A, Arizcun A, Pujol E, Diz P, et al.
Am J Clin Oncol . 2003 Apr; 26(2):127-31. PMID: 12714881
The aim of this study was to determine the efficacy and toxicity of a biweekly combination of docetaxel and vinorelbine in patients with metastatic breast cancer (MBC) previously treated with...